MH

Max Healthcare

Q1 FY27Healthcare Services

Max Healthcare Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price986
Market cap₹97.3K Cr
P/E65.0
Updated25 Aug 2026
Read4 min read

What the Q1 FY27 call signalled

2 of 4 strong

RevenueRank 3
MarginRank 3
CapexYes
FundraiseYes

Not discussed on this call: order book.

The short version

Continued capacity expansion across key locations (Lucknow, Noida, Nagpur) leading to higher occupancy and revenue growth. Revenue growth momentum remains strong with 16% year-on-year growth in Q1 FY27.

From Max Healthcare's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Rank 3
  • Continued capacity expansion across key locations (Lucknow, Noida, Nagpur) leading to higher occupancy and revenue growth.
  • New brownfield capacity additions expected to contribute directly to bottom-line profitability.
  • Incremental beds being added at Nanavati and Max Smart, with occupancy ramping up to around 80%, suggesting strong revenue and EBITDA growth potential.
  • Commissioning of new hospital beds phased over quarters, with EBITDA impact expected from Q2-Q3 onward.
  • Long-term outlook supports steady ARPOB growth of 7-8%, outpacing inflation due to innovation and novel treatments.
  • Institutional revenue share expected to decline gradually due to changing mix.
  • Planned capital expenditure on new hospital towers (e.g., Max Vaishali) enhancing bed capacity before FY30.
  • Expansion into medical education business anticipated to generate new revenue streams in the coming years.

Profitability & Margins

See what Max Healthcare said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Yes
  • Approved capex of INR 425 crore for a new brownfield tower at Max Vaishali adding 202 beds; construction started, commissioning expected before FY30.
  • Ongoing capacity expansions include:
  • - 100 beds at Max Lucknow (commissioning next two quarters)
  • - 500 beds at Sector 56 Gurgaon (phased commissioning from end of this year)
  • - 250 beds at Bhubaneswar (renovations to complete within 12 months)
  • - 100 beds at Nagpur (commissioning by FY28)
  • - 400 beds at Zirakpur, Mohali (commissioning in FY28)
  • - Onco day care block at Max Dwarka (awaiting occupancy certificate)
  • - 260 beds at Dwarka (commission by FY30)
  • - 200 beds at Pitampura (commission by FY29)
  • - 400 beds at Patparganj (work started, commissioning by end FY29)
  • - 271 beds at Nanavati Phase 2 (commission by FY30)
  • - 450 beds at Pune (IOD received, commissioning by FY30)
  • Plans to start medical education business with significant capex (~INR 300 crore per 150-seat college) funded through internal accruals.

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential
Rev 1Mar 1
2CHANDAN
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 2
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Max Healthcare said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention any current or expected order book or pending orders for Max Healthcare Institute Limited. The discussion mainly centers around operational capacity expansion, regulatory approvals, and project timelines for new hospitals and expansions, including: - Ongoing brownfield capacity expansions in Lucknow, Noida, and Nagpur with positive ramp-up. - Multiple bed additions planned across locations such as Vaishali, Bhubaneswar, Nagpur, Zirakpur, Dwarka, Pitampura, Patparganj, Nanavati, and Pune with commissioning dates through FY29 and FY30. - For Thane and Shaheed Path projects, regulatory approvals are underway with delivery expected 30-36 months after approvals (approximately after six months). - Expansion projects are proceeding as scheduled; no mention of formal orders or contracts backlog is given. Thus, the focus is on organic capacity build-out and regulatory progress rather than listing specific pending orders or an order book.

Max Healthcare — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹2.1K Cr, net profit ₹342 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • Manipal Health Enterprises Ltd (Q1 FY27)

    Volume-led growth with inpatient (IP) volumes up 39% and outpatient (OP) volumes up 26% year-on-year. Key concall takeaways from Manipal Health Enterprises…

  • Fortis Healthcare Ltd (Q1 FY27)

    IHH plans to increase its stake in Fortis to over 50% within 3-5 years, supporting long-term strategic growth. Key concall takeaways from Fortis Healthcare…

  • Metropolis Healthcare Ltd (Q1 FY27)

    East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…

  • Apollo Hospitals Enterprise Ltd (Q1 FY27)

    IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Max Healthcare Q1 FY27 results?

Continued capacity expansion across key locations (Lucknow, Noida, Nagpur) leading to higher occupancy and revenue growth. Revenue growth momentum remains strong with 16% year-on-year growth in Q1 FY27.

What is Max Healthcare share price analysis?

Max Healthcare currently shows a below-average growth signal. The stock trades at a P/E of 65.0 with a market cap of ₹97,328 Cr. Investors should review the full earnings analysis for detailed insights.

Is Max Healthcare planning capital expenditure?

Approved capex of INR 425 crore for a new brownfield tower at Max Vaishali adding 202 beds; construction started, commissioning expected before FY30.

Keep Max Healthcare on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.